• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CRITICAL CARE AB SERVO-I; VENTILATOR, CONTINUOUS, FACILITY USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CRITICAL CARE AB SERVO-I; VENTILATOR, CONTINUOUS, FACILITY USE Back to Search Results
Model Number SERVO-I
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Event Date 11/01/2019
Event Type  Injury  
Event Description
During literature review, an adverse event was identified in netherlands journal of critical care: neurally adjusted ventilatory assist catheter entering the pleural cavity the patient was admitted to the intensive care unit (icu) requiring noradrenaline, renal replacement therapy and invasive ventilation.After 14 days of mechanical ventilation, a tracheal cannula was inserted.Subsequently, a neutrally adjusted ventilatory assist (nava) catheter was introduced to facilitate ventilation and weaning from the ventilator.The catheter was introduced using forward head flexion and the nurse reported no resistance.According to protocol, the ph of the aspirate was checked to confirm correct placement.The ph of the aspirate was >7 and therefore a chest radiograph was performed to check the position of the inserted catheter.The catheter was inadvertently misplaced in the right bronchus with the tip projecting over the right upper lung field.Computed tomography was performed and confirmed the malposition of the nava catheter in the right lower bronchus, subsequently perforating the right lower lobe of the lung, entering the pleural cavity with the tip toward the apex.No leakage of air was observed on the ventilator, suggesting that the catheter itself plugged the perforation.The surgeon on duty was consulted.Surgical or thoracoscopic removal of the nava catheter was not considered beneficial over manual removal to avoid pneumothorax.Despite careful manual removal of the nava catheter, a tension pneumothorax developed with subsequent asystole cardiac arrest.Cardiopulmonary resuscitation was performed and chest tubes were placed both laterally and ventrally with rapid return of spontaneous circulation.The patient awoke with a good neurological status without any sequelae.After three days the chest tubes were successfully removed.Despite this full recovery, the patient passed away nine days later due to recurrent cholangitis related to the mucinous cystic carcinoma and the decision to withhold escalating interventions.Manufacturer's ref: (b)(4).
 
Event Description
Manufacturer's ref #: (b)(4).
 
Manufacturer Narrative
No parts or ventilator logs were returned.Further information was requested but no response has been received.Due to the limited information provided, no investigation has been possible.Therefore the root cause of the reported event has not been determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERVO-I
Type of Device
VENTILATOR, CONTINUOUS, FACILITY USE
Manufacturer (Section D)
MAQUET CRITICAL CARE AB
roentgenvagen 2
solna
MDR Report Key10948757
MDR Text Key220754156
Report Number3013876692-2020-00068
Device Sequence Number1
Product Code CBK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 02/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSERVO-I
Device Catalogue Number6487800
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA02/18/2021
Distributor Facility Aware Date02/18/2021
Event Location Hospital
Date Report to Manufacturer02/18/2021
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/04/2020
Supplement Dates Manufacturer Received02/18/2021
Supplement Dates FDA Received02/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age65 YR
-
-